Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Centrus International was a diagnostics company specializing in rapid microbiology testing solutions for the food, dairy, meat, and nutraceutical industries. Originally established as a subsidiary of Eastman Chemical Company, the firm developed and marketed the Soleris (formerly BioSys) and Envisio systems, which utilize optical technology to detect microbial contamination significantly faster than traditional culture methods. These platforms were designed to identify a wide range of organisms, including pathogens like E. coli and Salmonella, as well as spoilage-related bacteria, yeasts, and molds. In 2006, Centrus International was acquired by Neogen Corporation for $3.3 million, allowing Neogen to integrate these rapid testing technologies into its broader food safety portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centrus International.